Skip to main content

Table 4 Carbapenem resistant Enterobacteriaceae determinants and susceptibility profiles

From: A review of -multidrug-resistant Enterobacteriaceae in a neonatal unit in Johannesburg, South Africa

Number

Organism

Carbapenemase Gene

Antibiotic Susceptibility

Amikacin

Ciprofloxacin

Ertapenem

Meropenem

Imipenem

1.

K. pneumoniae

*NT

**R

***S

R

R

S

2.

K. pneumoniae

NT

****I

S

R

I

S

3.

K. pneumoniae

NDM

R

S

NT

R

R

4.

K. pneumoniae

NDM

R

R

R

R

R

5.

K. pneumoniae

NDM

S

S

NT

R

R

6.

K. pneumoniae

NDM

R

S

R

R

R

7.

K. pneumoniae

VIM

S

S

S

R

R

8.

K. pneumoniae

NT

S

S

R

R

R

9.

K. pneumoniae

NT

S

S

R

R

R

10.

K. pneumoniae

NDM

S

S

NT

R

R

11.

K. pneumoniae

NDM

S

S

R

R

R

12.

K. pneumoniae

NDM

R

S

NT

R

R

13.

K. pneumoniae

NDM

R

S

NT

R

R

14.

K. pneumoniae

NDM

S

S

NT

R

R

15.

K. pneumoniae

NDM

S

S

R

R

R

16.

K. pneumoniae

NDM

R

S

NT

R

R

17.

K. pneumoniae

NDM

R

S

R

R

R

18.

K. pneumoniae

NDM

S

S

NT

R

R

19.

K. pneumoniae

NDM

S

S

NT

R

R

20.

K. pneumoniae

NT

S

S

R

R

R

21.

K. pneumoniae

NEG

S

S

R

R

R

22.

K. pneumoniae

NT

S

R

R

S

I

23.

K. oxytoca

VIM

S

S

NT

R

R

24.

E. cloacae

NT

S

S

S

S

R

25.

E. cloacae

NT

S

S

R

S

S

26.

C. freundii

NDM

R

S

R

R

R

  1. NT- not tested
  2. **R- resistant
  3. ***S- susceptible
  4. ****I- intermediately-susceptible
  5. The susceptibility to Amikacin and/or Ciprofloxacin allows these antibiotics to be considered as treatment options either as (1) monotherapy or (2) in combination with each other or (3) in combination with a carbapenem, which spares colistin use